These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Optogenetic approaches for investigating neural pathways implicated in schizophrenia and related disorders. Cho KK; Sohal VS Hum Mol Genet; 2014 Sep; 23(R1):R64-8. PubMed ID: 24824218 [TBL] [Abstract][Full Text] [Related]
43. Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain. Lee D; Creed M; Jung K; Stefanelli T; Wendler DJ; Oh WC; Mignocchi NL; Lüscher C; Kwon HB Nat Methods; 2017 May; 14(5):495-503. PubMed ID: 28369042 [TBL] [Abstract][Full Text] [Related]
44. Modeling the Spatiotemporal Dynamics of Light and Heat Propagation for In Vivo Optogenetics. Stujenske JM; Spellman T; Gordon JA Cell Rep; 2015 Jul; 12(3):525-34. PubMed ID: 26166563 [TBL] [Abstract][Full Text] [Related]
45. A novel analgesic approach to optogenetically and specifically inhibit pain transmission using TRPV1 promoter. Li B; Yang XY; Qian FP; Tang M; Ma C; Chiang LY Brain Res; 2015 Jun; 1609():12-20. PubMed ID: 25797803 [TBL] [Abstract][Full Text] [Related]
46. Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9. Masamizu Y; Okada T; Kawasaki K; Ishibashi H; Yuasa S; Takeda S; Hasegawa I; Nakahara K Neuroscience; 2011 Oct; 193():249-58. PubMed ID: 21782903 [TBL] [Abstract][Full Text] [Related]
47. Optogenetics and Chemogenetics. Vlasov K; Van Dort CJ; Solt K Methods Enzymol; 2018; 603():181-196. PubMed ID: 29673525 [TBL] [Abstract][Full Text] [Related]
48. Effect of optogenetic manipulation of accumbal medium spiny neurons expressing dopamine D2 receptors in cocaine-induced behavioral sensitization. Kang BJ; Song SS; Wen L; Hong KP; Augustine GJ; Baik JH Eur J Neurosci; 2017 Aug; 46(4):2056-2066. PubMed ID: 28708260 [TBL] [Abstract][Full Text] [Related]
49. [Therapeutic potential of optogenetic neuromodulation]. Vandecasteele M; Senova YS; Palfi S; Dugué GP Med Sci (Paris); 2015 Apr; 31(4):404-16. PubMed ID: 25958759 [TBL] [Abstract][Full Text] [Related]
50. Principles of designing interpretable optogenetic behavior experiments. Allen BD; Singer AC; Boyden ES Learn Mem; 2015 Apr; 22(4):232-8. PubMed ID: 25787711 [TBL] [Abstract][Full Text] [Related]
51. Microbial Rhodopsin Optogenetic Tools: Application for Analyses of Synaptic Transmission and of Neuronal Network Activity in Behavior. Glock C; Nagpal J; Gottschalk A Methods Mol Biol; 2015; 1327():87-103. PubMed ID: 26423970 [TBL] [Abstract][Full Text] [Related]
52. Optogenetic Tools for Subcellular Applications in Neuroscience. Rost BR; Schneider-Warme F; Schmitz D; Hegemann P Neuron; 2017 Nov; 96(3):572-603. PubMed ID: 29096074 [TBL] [Abstract][Full Text] [Related]
53. High-efficiency transduction and specific expression of ChR2opt for optogenetic manipulation of primary cortical neurons mediated by recombinant adeno-associated viruses. Jin L; Lange W; Kempmann A; Maybeck V; Günther A; Gruteser N; Baumann A; Offenhäusser A J Biotechnol; 2016 Sep; 233():171-80. PubMed ID: 27416794 [TBL] [Abstract][Full Text] [Related]